Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 April 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Gastrointestinal cancer risk with iron-deficiency anemia

Risk factors include male sex, age over 50 years and haemoglobin at presentation, and iron-deficiency anemia should not be attributed to aspirin, non-steroidal anti-inflammatory drugs or warfarin use, reports the latest issue of the European Journal of Gastroenterology & Hepatology.

News image

fiogf49gjkf04

Iron-deficiency anemia is common and may be caused by blood loss from gastrointestinal tumours.

Dr Martin James and colleagues defined risk factors for gastrointestinal malignancy in patients with Iron-deficiency anemia.

Patients with suspected Iron-deficiency anemia referred for gastrointestinal investigations were prospectively identified.

The patients were included between 1998 and 1999 from 2 neighbouring UK hospitals serving a population of 550,000 patients.

Final diagnoses were determined after 2 years.

The researchers then compared those patients with and without gastrointestinal cancer as a cause for their iron-deficiency anemia.

Data collected included sex, age, haemoglobin, serum ferritin, mean cell volume and drug history.

Gastrointestinal cancer was diagnosed in 11% of patients with iron-deficiency anemia
Journal of Gastroenterology & Hepatology

The research team investigated a total of 695 patients, of which 236 were men with a mean age of 69 years, and 459 women with a mean age of 66 years.

All patients presented with iron-deficiency anemia.

The team diagnosed malignancy in 13% and gastrointestinal malignancy in 11%.

The team found that the most frequently diagnosed cancers were colonic at 6%, gastric occurring in 4%, and renal tract in 1% of patients.

The adjusted odds ratio for gastrointestinal cancer as a cause of iron-deficiency anemia was significantly higher for male sex, and age over 50 years.

The researchers also noted that hemoglobin level at presentation had higher odds ratios for gastrointestinal cancer as a cause of iron-deficiency anemia.

There was no significant difference in gastrointestinal malignancy in those taking aspirin, and non-aspirin drugs compared with those not taking the drugs.

The team found no difference in gastrointestinal malignancy with non-steroidal anti-inflammatory drugs or warfarin compared with not taking these drug.

No cause for iron-deficiency anemia was found in 54%.

Dr James' team commented, “Cancer was diagnosed in 13% and gastrointestinal cancer in 11% of patients with iron-deficiency anemia.”

“Significant risk factors for gastrointestinal malignancy in iron-deficiency anemia patients are male sex, age over 50 years and haemoglobin at presentation.”

“Iron-deficiency anemia should not be attributed to aspirin, non-steroidal anti-inflammatory drugs or warfarin use.”

Eur J Gastroenterol Hepatol 2005: 17(11): 1197-1203
20 October 2005

Go to top of page Email this page Email this page to a colleague

 19 April 2018 
Fibrosis in patients with chronic hepatitis B
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA
 18 April 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 18 April 2018 
Hep C treatment for sustained virologic response
 18 April 2018 
Endoscopic necrosectomy reduces risk of death 
 17 April 2018 
Colorectal cancer screening and ethnic inequities
 17 April 2018 
Training programs should consider radiation education for advanced endoscopy fellows
 17 April 2018 
Aspirin and pancreatic cancer
 16 April 2018 
Surgery for colorectal polyps has increased 
 16 April 2018 
Advanced fibrosis can be ruled out in primary health care patients
 16 April 2018 
Antibiotic use and colorectal adenoma
 13 April 2018 
Colorectal cancer cell lines
 13 April 2018 
Infliximab and corticosteroid-free clinical remission in Crohn's
 13 April 2018 
Teduglutide for children with short bowel syndrome
 12 April 2018 
Prescriptions for opiate drugs amongst primary care patients with IBD
 12 April 2018 
Lower GI bleeding related to comorbidity
 12 April 2018 
non–Clostridium difficile bacterial infections in IBD
 11 April 2018 
Physician perception of IBD trial results
 11 April 2018 
Bile acid deficiency in IBS 
 11 April 2018 
Stem cell therapy for fistulas in Crohn's
 10 April 2018 
Overweight in childhood and type 2 diabetes
 10 April 2018 
immunoglobulin G associates with clinical features of IBD
 10 April 2018 
T-cells repertoires in celiac disease
 09 April 2018 
Biomarker tests for colorectal cancer screening
 09 April 2018 
Fecal transplantation in C. difficile infection and treatment outcome 
 09 April 2018 
No weigh-loss drug improved all cardiometabolic risk factors
 06 April 2018 
Colonoscopy and colorectal cancer mortality
 06 April 2018 
Eosinophilic esophagitis and health-related quality of life
 06 April 2018 
Microbiome in athletes vs sedentary subjects
 05 April 2018 
Laparoscopic Nissen fundoplication for GERD treatment
 05 April 2018 
Random biopsies for neoplasia in IBD
 05 April 2018 
Scoring system identifies cancer risk in Barrett's
 04 April 2018 
Alpha‐1 antitrypsin deficiency and liver disease
 04 April 2018 
PPI and risk of stroke
 04 April 2018 
Adjuvant chemotherapy for advanced colon cancer
 29 March 2018 
Worldwide H.pylori prevalence
 29 March 2018 
Prevention of metachronous gastric cancer
 29 March 2018 
Acute lower GI bleeding
 28 March 2018 
Decision aid used by IBD patients
 28 March 2018 
Transition for young adults with IBD
 28 March 2018 
Amitriptyline in functional dyspepsia
 27 March 2018 
Emergency department utilization for IBD 
 27 March 2018 
Management of hemorrhoids in the USA
 27 March 2018 
Adult ulcerative colitis
 26 March 2018 
Biological therapy response in IBD 
 26 March 2018 
Obesity and diverticulosis
 26 March 2018 
Practice guidelines for chronic constipation
 23 March 2018 
Health-related quality of life in eosinophilic esophagitis
 23 March 2018 
Genetics and chronic liver disease
 23 March 2018 
Global prevalence of H.pylori
 22 March 2018 
H. pyloris and gastric cancer
 22 March 2018 
Pancreatitis after IBS treatment 
 22 March 2018 
Mechanisms of action in patients with IBS
 21 March 2018 
Panel markers for early detection of colon cancer

 21 March 2018 
Blood test differentiates celiac disease
 21 March 2018 
Patient characteristics and colonoscopy preparation
 20 March 2018 
Bloody vs coffee-grounds hematemesis
 20 March 2018 
Acute lower GI bleeding in the UK
 20 March 2018 
Therapeutic strategies for IBD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us